Back to Search Start Over

Sleep to Reduce Incident Depression Effectively (STRIDE): Study protocol for a randomized controlled trial comparing stepped-care cognitive behavioral therapy for insomnia versus sleep education control to prevent major depression

Authors :
Christopher L Drake
David A Kalmbach
Philip Cheng
Brian K Ahmedani
Edward L Peterson
Christine LM Joseph
Thomas Roth
Kelley M Kidwell
Chaewon Sagong
Publication Year :
2022
Publisher :
Research Square Platform LLC, 2022.

Abstract

Background Prevention of major depressive disorder (MDD) is a public health priority. Strategies targeting individuals at elevated risk for MDD may guide effective preventive care. Insomnia is a reliable precursor to depression, preceding half of all incident and relapse cases. Thus, insomnia may serve as a useful entry point for preventing MDD. Cognitive-behavioral therapy for insomnia (CBT-I) is recommended as first-line treatment for insomnia, but widespread implementation is limited by a shortage of trained specialists. Innovative stepped-care approaches rooted in primary care can increase access to CBT-I and reduce rates of MDD. Methods/Design: We propose a large-scale stepped-care clinical trial in the primary care setting that utilizes a sequential, multiple assignment, randomized trial (SMART) design to determine the effectiveness of dCBT-I alone and in combination with clinician-led CBT-I for insomnia and the prevention of MDD incidence and relapse. Specifically, our care model uses digital CBT-I (dCBT-I) as a first-line intervention to increase care access and reduce need for specialist resources. Our proposal also adds clinician-led CBT-I for patients who do not remit with first-line intervention and need a more personalized approach from specialty care. We will evaluate negative repetitive thinking as a potential treatment mechanism by which dCBT-I and CBT-I benefit insomnia and depression outcomes. Discussion This project will test a highly scalable model of sleep care in a large primary care system to determine the potential for wide dissemination and implementation to address the high volume of population-need for safe and effective insomnia treatment and associated prevention of depression. Trial Registration: NCT03322774. Date of registration, October 26, 2017.

Details

Database :
OpenAIRE
Accession number :
edsair.doi...........684a15518de9667146103ac69ebcd26c
Full Text :
https://doi.org/10.21203/rs.3.rs-1946557/v1